fda semaglutide compounding news Diabetes advocacy group discourages use of compounded GLP-1 drugs FDA's Removal of Semaglutide and

More studies should be done to untangle those underlying mechanisms and to more clearly understand the severity and reversibility of GLP-1-induced hair loss, the researchers say

Signs you are escalating too fast Watch for these indicators that your dose is advancing too quickly for your postpartum body: Persistent nausea lasting more than three days after a dose increase Inability to consume at least 1,500 calories daily (1,800 or more if breastfeeding) Noticeable drop in breast milk supply Fatigue significantly worse than your postpartum baseline Weight loss exceeding three pounds per week consistently Dizziness or lightheadedness, especially when standing If any of these occur, the standard recommendation is to hold at your current dose for an additional four weeks before attempting another increase

He explained that the hardest part was simply being able to get his prescription filled

PMID: 21094897

Whether youre currently treating breast cancer or have completed treatment, you might wonder if these drugs are safe for you